Comparison of 3-year EFS rates by presenting features in infants with MLL+ ALL
Feature . | No. of patients . | EFS (%) . | P . |
|---|---|---|---|
| Age, mo | |||
| Younger than 6 | 25 | 28.0 | .0499 |
| 6 or older | 19 | 63.2 | |
| Gender | |||
| Male | 19 | 44.9 | .8470 |
| Female | 25 | 42.7 | |
| WBC count, × 109/L | |||
| Less than 100 | 20 | 53.3 | .1867 |
| 100 or higher | 24 | 35.2 | |
| Less than 200 | 30 | 46.9 | .5861 |
| 200 or higher | 14 | 35.7 | |
| Less than 300 | 35 | 46.1 | .7018 |
| 300 or higher | 9 | 33.3 | |
| CNS involvement | |||
| Positive | 10 | 10.0 | .0073 |
| Negative | 31 | 56.9 | |
| Karyotype | |||
| 4:11 translocation | 27 | 37.0 | .1763 |
| Other | 17 | 56.3 |
Feature . | No. of patients . | EFS (%) . | P . |
|---|---|---|---|
| Age, mo | |||
| Younger than 6 | 25 | 28.0 | .0499 |
| 6 or older | 19 | 63.2 | |
| Gender | |||
| Male | 19 | 44.9 | .8470 |
| Female | 25 | 42.7 | |
| WBC count, × 109/L | |||
| Less than 100 | 20 | 53.3 | .1867 |
| 100 or higher | 24 | 35.2 | |
| Less than 200 | 30 | 46.9 | .5861 |
| 200 or higher | 14 | 35.7 | |
| Less than 300 | 35 | 46.1 | .7018 |
| 300 or higher | 9 | 33.3 | |
| CNS involvement | |||
| Positive | 10 | 10.0 | .0073 |
| Negative | 31 | 56.9 | |
| Karyotype | |||
| 4:11 translocation | 27 | 37.0 | .1763 |
| Other | 17 | 56.3 |